[MOL] Abstracts on cancer drugs.... [02425] Medicine On Line


[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

[MOL] Abstracts on cancer drugs....



http://webmedlit.silverplatter.com/j/39acff4e8b/

Cancer Chemotherapy and Pharmacology

ISSN: 0344-5704 (printed version)
ISSN: 1432-0843 (electronic version)

Table of Contents Vol. 46 Issue 3

Jeff D. Moore, Bruce J. Dezube, Parkash Gill, Xiao-Jian Zhou, Edward P. Acosta, Jean-Pierre Sommadossi:
Phase I dose escalation pharmacokinetics of O-(chloroacetylcarbamoyl) fumagillol (TNP-470) and its metabolites in AIDS patients with Kaposi's sarcoma
Cancer Chemother Pharmacol 46 (2000) 3, 173-179
Article in PDF format (118 KB)

Sotaro Sadahiro, Shigeru Ohki, Shigeki Yamaguchi, Toshiki Takahashi, Yoshimasa Otani, Satoshi Tsukikawa, Takuya Yamamura, Shoji Takemiya, Hideaki Nagasaki, Kiyoshi Nishiyama, Tsuneo Fukushima, Yoshiki Hiki, Susumu Yamaguchi, Kaoru Kumada, Hiroshi Shimada, Toshio Mitomi, Hiroyasu Makuuchi:
Feasibility of a novel weekday-on/weekend-off oral UFT schedule as postoperative adjuvant chemotherapy for colorectal cancer
Cancer Chemother Pharmacol 46 (2000) 3, 180-184
Article in PDF format (85 KB)

Sujata Vaidyanathan, Mehdi Boroujerdi:
Effect of tamoxifen pretreatment on the pharmacokinetics, metabolism and cardiotoxicity of doxorubicin in female rats
Cancer Chemother Pharmacol 46 (2000) 3, 185-192
Article in PDF format (151 KB)

Philip W. Wills, Robert Hickey, Linda Malkas:
Ara-C differentially affects multiprotein forms of human cell DNA polymerase
Cancer Chemother Pharmacol 46 (2000) 3, 193-203
Article in PDF format (208 KB)

Saad Akhtar, Robert A. Beckman, Diane R. Mould, Edward Doyle, Scott Z. Fields, Jonathan Wright:
Pretreatment with ranitidine does not reduce the bioavailability of orally administered topotecan
Cancer Chemother Pharmacol 46 (2000) 3, 204-210
Article in PDF format (115 KB)

Akinobu Kurita, Shoichi Kado, Norimasa Kaneda, Masaharu Onoue, Shusuke Hashimoto, Teruo Yokokura:
Modified irinotecan hydrochloride (CPT-11) administration schedule improves induction of delayed-onset diarrhea in rats
Cancer Chemother Pharmacol 46 (2000) 3, 211-220
Article in PDF format (263 KB)

Deborah W. Knapp, Nita W. Glickman, William R. Widmer, Dennis B. DeNicola, Larry G. Adams, Thomas Kuczek, Patty L. Bonney, Amalia E. DeGortari, Connie Han, Lawrence T. Glickman:
Cisplatin versus cisplatin combined with piroxicam in a canine model of human invasive urinary bladder cancer
Cancer Chemother Pharmacol 46 (2000) 3, 221-226
Article in PDF format (89 KB)

D. Ouellet, A. P. Periclou, R. D. Johnson, J. R. Woodworth, R. L. Lalonde:
Population pharmacokinetics of pemetrexed disodium (ALIMTA) in patients with cancer
Cancer Chemother Pharmacol 46 (2000) 3, 227-234
Article in PDF format (154 KB)

Osama M. Ashour, Fardos N. M. Naguib, Naganna M. Goudgaon, Raymond F. Schinazi, Mahmoud H. el Kouni:
Effect of 5-(phenylselenenyl)acyclouridine, an inhibitor of uridine phosphorylase, on plasma concentration of uridine released from 2',3',5'-tri-O-acetyluridine, a prodrug of uridine: relevance to uridine rescue in chemotherapy
Cancer Chemother Pharmacol 46 (2000) 3, 235-240
Article in PDF format (106 KB)

Hiroshi Mese, Akira Sasaki, Shuko Nakayama, Rafael E. Alcalde, Tomohiro Matsumura:
The role of caspase family protease, caspase-3 on cisplatin-induced apoptosis in cisplatin-resistant A431 cell line
Cancer Chemother Pharmacol 46 (2000) 3, 241-245
Article in PDF format (113 KB)

William C. Rose, Francis Y. F. Lee, Jerzy Golik, John Kadow:
Preclinical oral antitumor activity of BMS-185660, a paclitaxel derivative
Cancer Chemother Pharmacol 46 (2000) 3, 246-250
Article in PDF format (99 KB)

Robert Pelley, Ram Ganapathi, Laura Wood, Lisa Rybicki, Denise McLain, G. Thomas Budd, David Peereboom, Thomas Olencki, Ronald M. Bukowski, G. Thomas Budd:
short communication: A phase II pharmacodynamic study of pyrazoloacridine in patients with metastatic colorectal cancer
Cancer Chemother Pharmacol 46 (2000) 3, 251-254
Article in PDF format (76 KB)

communication
: A phase II pharmacodynamic study of pyrazoloacridine in patients with metastatic colorectal cancer

Preclinical oral antitumor activity of BMS-185660, a paclitaxel derivative
 
 
 
We invite you to take a look at our Album.                                               
www.angelfire.com/sc/molangels/index.html
 
  ( Very informational, good tips, Molers pictures, art work and much more....